freshpet - FRPT
FRPT
Close Chg Chg %
153.00 3.11 2.03%
Open Market
156.11
+3.11 (2.03%)
Volume: 201.07K
Last Updated:
Nov 21, 2024, 1:58 PM EDT
Company Overview: freshpet - FRPT
FRPT Key Data
Open $152.53 | Day Range 152.01 - 156.90 |
52 Week Range 68.26 - 159.12 | Market Cap $7.43B |
Shares Outstanding 48.54M | Public Float 47.85M |
Beta 1.39 | Rev. Per Employee N/A |
P/E Ratio 173.90 | EPS $0.91 |
Yield 0.00% | Dividend N/A |
EX-DIVIDEND DATE | SHORT INTEREST N/A |
AVERAGE VOLUME 599.62K |
FRPT Performance
1 Week | 2.00% | ||
1 Month | 14.49% | ||
3 Months | 10.20% | ||
1 Year | 120.78% | ||
5 Years | 186.17% |
FRPT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
20
Full Ratings ➔
About freshpet - FRPT
Freshpet, Inc. engages in the manufacturing, marketing, and distribution of pet food and pet treats for dogs and cats. Its products are blends of fresh meats, vegetables and fruits farmed locally and made at Freshpet kitchens. Its products include Deli Fresh Grain Free Chicken Recipe for Dogs, Joy Turkey and Apple Bites Treats, Nature's Fresh Grain Free Chicken Recipe for Cats, and Vital Grain Free Chicken and Ocean Whitefish Recipe for Cats. The company was founded by Scott Morris and Cathal Walsh in November 2004 and is headquartered in Bedminster, NJ.
FRPT At a Glance
Freshpet, Inc.
1545 US-206
Bedminster, New Jersey 07921
Phone | 1-201-520-4000 | Revenue | 766.90M | |
Industry | Food: Specialty/Candy | Net Income | -33,614,000.00 | |
Sector | Consumer Non-Durables | 2023 Sales Growth | 28.815% | |
Fiscal Year-end | 12 / 2024 | Employees | 1,083 | |
View SEC Filings |
FRPT Valuation
P/E Current | 173.903 |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | N/A |
Price to Sales Ratio | 5.449 |
Price to Book Ratio | 4.392 |
Price to Cash Flow Ratio | 55.025 |
Enterprise Value to EBITDA | 149.656 |
Enterprise Value to Sales | 5.616 |
Total Debt to Enterprise Value | 0.099 |
FRPT Efficiency
Revenue/Employee | 708,120.96 |
Income Per Employee | -31,037.858 |
Receivables Turnover | 13.513 |
Total Asset Turnover | 0.592 |
FRPT Liquidity
Current Ratio | 4.789 |
Quick Ratio | 4.081 |
Cash Ratio | 3.327 |
FRPT Profitability
Gross Margin | 30.646 |
Operating Margin | -3.878 |
Pretax Margin | -4.109 |
Net Margin | -4.383 |
Return on Assets | -2.596 |
Return on Equity | -3.387 |
Return on Total Capital | -2.438 |
Return on Invested Capital | -2.788 |
FRPT Capital Structure
Total Debt to Total Equity | 44.581 |
Total Debt to Total Capital | 30.834 |
Total Debt to Total Assets | 29.025 |
Long-Term Debt to Equity | 44.233 |
Long-Term Debt to Total Capital | 30.594 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Freshpet - FRPT
Collapse All in section
All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 318.79M | 425.49M | 595.34M | 766.89M | |
Sales Growth
| +29.66% | +33.47% | +39.92% | +28.82% | |
Cost of Goods Sold (COGS) incl D&A
| 193.91M | 275.51M | 423.09M | 531.87M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 21.13M | 31.80M | 35.93M | 58.52M | |
Depreciation
| 20.80M | 30.80M | 35.70M | 58.17M | |
Amortization of Intangibles
| 325.00K | 1.00M | 223.00K | 348.00K | |
COGS Growth
| +37.31% | +42.08% | +53.57% | +25.71% | |
Gross Income
| 124.88M | 149.98M | 172.25M | 235.02M | |
Gross Income Growth
| +19.34% | +20.09% | +14.85% | +36.44% | |
Gross Profit Margin
| +39.17% | +35.25% | +28.93% | +30.65% |
2020 | 2021 | 2022 | 2023 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 121.22M | 171.88M | 223.10M | 264.76M | |
Research & Development
| - | - | - | 800.00K | - |
Other SG&A
| 120.42M | 171.88M | 223.10M | 264.76M | |
SGA Growth
| +15.56% | +41.79% | +29.80% | +18.67% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 3.85M | 1.76M | 734.00K | (67.00K) | |
EBIT after Unusual Expense
| (193.00K) | (23.66M) | (51.59M) | (29.67M) | |
Non Operating Income/Expense
| (1.72M) | (987.00K) | 1.31M | 12.26M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 1.21M | 2.88M | 5.21M | 14.10M | |
Interest Expense Growth
| +22.33% | +137.79% | +80.71% | +170.68% | |
Gross Interest Expense
| 1.21M | 2.88M | 5.21M | 14.10M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (3.12M) | (27.53M) | (55.48M) | (31.51M) | |
Pretax Income Growth
| -152.14% | -781.59% | -101.51% | +43.20% | |
Pretax Margin
| -0.98% | -6.47% | -9.32% | -4.11% | |
Income Tax
| 65.00K | 162.00K | 282.00K | 210.00K | |
Income Tax - Current - Domestic
| 65.00K | 162.00K | 282.00K | 210.00K | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (3.19M) | (29.70M) | (59.49M) | (33.61M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (3.19M) | (29.70M) | (59.49M) | (33.61M) | |
Net Income Growth
| -130.56% | -831.59% | -100.32% | +43.50% | |
Net Margin Growth
| -1.00% | -6.98% | -9.99% | -4.38% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (3.19M) | (29.70M) | (59.49M) | (33.61M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (3.19M) | (29.70M) | (59.49M) | (33.61M) | |
EPS (Basic)
| -0.0802 | -0.6918 | -1.288 | -0.6979 | |
EPS (Basic) Growth
| -108.31% | -762.59% | -86.18% | +45.82% | |
Basic Shares Outstanding
| 39.76M | 42.93M | 46.19M | 48.16M | |
EPS (Diluted)
| -0.0802 | -0.6918 | -1.288 | -0.6979 | |
EPS (Diluted) Growth
| -108.31% | -762.59% | -86.18% | +45.82% | |
Diluted Shares Outstanding
| 39.76M | 42.93M | 46.19M | 48.16M | |
EBITDA
| 24.79M | 9.89M | (14.93M) | 28.78M | |
EBITDA Growth
| +58.19% | -60.09% | -250.89% | +292.80% | |
EBITDA Margin
| +7.78% | +2.32% | -2.51% | +3.75% |
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 170.412 | |
Number of Ratings | 20 | Current Quarters Estimate | 0.401 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | 0.906 | |
Last Quarter’s Earnings | 0.24 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | -0.70 | Next Fiscal Year Estimate | 1.527 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 9 | 9 | 11 | 11 |
Mean Estimate | 0.40 | 0.25 | 0.91 | 1.53 |
High Estimates | 0.53 | 0.37 | 1.04 | 2.05 |
Low Estimate | 0.31 | 0.14 | 0.70 | 1.07 |
Coefficient of Variance | 17.49 | 31.52 | 10.51 | 23.07 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 14 | 14 | 14 |
OVERWEIGHT | 1 | 1 | 1 |
HOLD | 3 | 4 | 4 |
UNDERWEIGHT | 2 | 1 | 1 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Freshpet - FRPT
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Freshpet - FRPT
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Jul 3, 2024 | Nishu Patel Chief Accounting Officer | 2,314 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.39 per share | 299,408.46 |
Jun 6, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 11,500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Jun 6, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 86,039 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $132.13 per share | 11,368,333.07 |
Jun 6, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 92,039 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $49.77 per share | 4,580,781.03 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 6,548 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 13, 2024 | Cathal Walsh SVP - Managing Director Europe | 6,291 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $111.28 per share | 700,062.48 |
May 13, 2024 | Cathal Walsh SVP - Managing Director Europe | 7,265 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 87,239 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $11 per share | 959,629.00 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 86,039 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $120.5 per share | 10,367,699.50 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 92,587 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $11 per share | 1,018,457.00 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 7,748 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 13, 2024 | Stephen M. Macchiaverna EVP, Treasurer | 86,039 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $120.15 per share | 10,337,585.85 |
Apr 12, 2024 | Lauri Kien Kotcher Director | 1,046 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 11, 2024 | Scott Morris President and COO | 122,380 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $109.86 per share | 13,444,666.80 |
Apr 11, 2024 | Scott Morris President and COO | 78,368 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Apr 11, 2024 | Scott Morris President and COO | 124,512 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $8.9 per share | 1,108,156.80 |
Mar 21, 2024 | Craig D. Steeneck Director | 30,479 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2024 | Jacki S. Kelley Director | 9,661 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2024 | Lawrence Stephen Coben Director | 52,833 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |